(RTTNews) - GE HealthCare announced the commencement of Thera4Care, an initiative aimed at revolutionizing the use of theranostics to broaden patient access in Europe. Thera4Care aims to expand the use of theranostics in Europe by creating, implementing, and disseminating standardized, scalable methods for the production, detection, and monitoring of key theranostic isotopes, from the manufacturing and early delivery of diagnostics through to therapy.
The company said the 25.3 million euros project gathers 29 partners from top European academic and clinical sites, small and medium-sized enterprises, and patient advocacy groups.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
